ORGANIZATION

• EFPIA Japan Official Calls for More-Effective Use of Surplus Raw Plasma
  October 30, 2014

• April-June Generic Share at 49.8% under New Formula: JGA
  October 29, 2014

• JPMA to Launch Compound Library Joint Purchasing Initiative; Full-Scale Purchasing to Begin in FY2015
  October 29, 2014

• FPMAJ Sets Up Panel to Discuss Selective Sales Tax Breaks
  October 27, 2014

• Japan CRO Association Nearing Remote Verification Agreement with Cancer Treatment Center
  October 22, 2014

• JPMA Tones Down Demand on R&D Tax Credit System, Calls for “Maintenance” Instead of “Perpetuation”
  October 20, 2014

• JMA Pres. Frets Proposed Introduction of Reference Pricing Rule
  October 17, 2014

• JPMA Decides on More Close-Up Disclosure for R&D Outlays
  October 17, 2014

• Industry Associations Call for Delay in Ratification of COP10 Nagoya Protocol
  October 10, 2014

• US Nonprofit ACRES Launches Japan Branch
  October 8, 2014

• National University Hospital Council’s Guidelines Not to Require Disclosure of Individuals’ Names
  October 7, 2014

• JPMA Plans Disclosure of Recipients, Amount of Payments for R&D Outlays
  October 3, 2014

• Bayer Yakuhin President to Become New EFPIA Japan Chairman
  October 2, 2014

• JPMA Weighs Disclosure of Ad Payments to Commercial Medical Publishers
  September 26, 2014

• JPMA to Unify Method of Disclosing Sensitive Payment Information from Next Year
  September 22, 2014

• JPMA to Suspend Hasegawa’s Veep Activities for Another 6 Months over CASE-J
  September 19, 2014

• CDISC CEO Advises Drug Makers to Collect Data Based on CDASH
  August 27, 2014

• NEDO, NCC, Toray to Jointly Develop Simple Test Systems for Cancers and Dementia
  August 20, 2014

• Fair Discussions Necessary for Full Introduction of New Drug Development Premium: Chuikyo Member
  August 12, 2014

• Drug Price Settlement Rate Will Rise towards Sept.: JPWA Chief
  August 11, 2014

ページ

• « 先頭
• ‹ Prev
• …
• 56
• 57
• 58
• 59
• 60
• 61
• 62
• 63
• 64
• …
• Next ›
• 最終 »